[HTML][HTML] The p53 pathway in glioblastoma
Y Zhang, C Dube, M Gibert Jr, N Cruickshanks, B Wang… - Cancers, 2018 - mdpi.com
The tumor suppressor and transcription factor p53 plays critical roles in tumor prevention by
orchestrating a wide variety of cellular responses, including damaged cell apoptosis …
orchestrating a wide variety of cellular responses, including damaged cell apoptosis …
When mutants gain new powers: news from the mutant p53 field
R Brosh, V Rotter - Nature reviews cancer, 2009 - nature.com
Ample data indicate that mutant p53 proteins not only lose their tumour suppressive
functions, but also gain new abilities that promote tumorigenesis. Moreover, recent studies …
functions, but also gain new abilities that promote tumorigenesis. Moreover, recent studies …
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
AA Ahmed, D Etemadmoghadam… - The Journal of …, 2010 - Wiley Online Library
Numerous studies have tested the association between TP53 mutations in ovarian cancer
and prognosis but these have been consistently confounded by limitations in study design …
and prognosis but these have been consistently confounded by limitations in study design …
Mutant p53 gain-of-function in cancer
M Oren, V Rotter - Cold Spring Harbor perspectives in …, 2010 - cshperspectives.cshlp.org
In its wild-type form, p53 is a major tumor suppressor whose function is critical for protection
against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding …
against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding …
Personalized characterization of diseases using sample-specific networks
A complex disease generally results not from malfunction of individual molecules but from
dysfunction of the relevant system or network, which dynamically changes with time and …
dysfunction of the relevant system or network, which dynamically changes with time and …
[HTML][HTML] PTEN tumor-suppressor: the dam of stemness in cancer
F Luongo, F Colonna, F Calapà, S Vitale, ME Fiori… - Cancers, 2019 - mdpi.com
PTEN is one of the most frequently inactivated tumor suppressor genes in cancer. Loss or
variation in PTEN gene/protein levels is commonly observed in a broad spectrum of human …
variation in PTEN gene/protein levels is commonly observed in a broad spectrum of human …
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes
Y Li, F Guessous, Y Zhang, C DiPierro, B Kefas… - Cancer research, 2009 - AACR
Abstract MicroRNA-34a (miR-34a) is a transcriptional target of p53 that is down-regulated in
some cancer cell lines. We studied the expression, targets, and functional effects of miR-34a …
some cancer cell lines. We studied the expression, targets, and functional effects of miR-34a …
Therapeutic targeting of cancers with loss of PTEN function
LM Dillon, TW Miller - Current drug targets, 2014 - ingentaconnect.com
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is one of the most
frequently disrupted tumor suppressors in cancer. The lipid phosphatase activity of PTEN …
frequently disrupted tumor suppressors in cancer. The lipid phosphatase activity of PTEN …
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Ataxia telangiectasia (AT) mutated (ATM) is critical for cell cycle checkpoints and DNA
repair. Thus, specific small molecule inhibitors targeting ATM could perhaps be developed …
repair. Thus, specific small molecule inhibitors targeting ATM could perhaps be developed …
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
We recently found that microRNA-34a (miR-34a) is downregulated in human glioma tumors
as compared to normal brain, and that miR-34a levels in mutant-p53 gliomas were lower …
as compared to normal brain, and that miR-34a levels in mutant-p53 gliomas were lower …